Bank of America Corp DE Acquires 171,554 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
Bank of America Corp DE Acquires 171,554 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
Bank of America Corp DE increased its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) by 36.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 639,632 shares of the medical instruments supplier's stock after purchasing an additional 171,554 shares during the period. Bank of America Corp DE's holdings in West Pharmaceutical Services were worth $262,703,000 at the end of the most recent quarter.
根據美國銀行最近向美國證券交易委員會(Securities and Exchange Commission，美國證券交易委員會)提交的文件，該公司在第一季度增持了West Pharmtics Services，Inc.(紐約證券交易所代碼：WST-GET評級)的股票36.7%。該機構投資者持有這家醫療器械供應商的639,632股股票，在此期間又購買了171,554股。截至最近一個季度末，美國銀行(Bank Of America Corp DE)在West Pharmtics Services持有的股份價值262,703,000美元。
Several other institutional investors have also modified their holdings of WST. ARK Investment Management LLC acquired a new stake in West Pharmaceutical Services in the 1st quarter valued at approximately $179,000. Mirae Asset Global Investments Co. Ltd. acquired a new stake in West Pharmaceutical Services in the 1st quarter valued at approximately $4,412,000. National Asset Management Inc. raised its position in West Pharmaceutical Services by 11.9% in the 1st quarter. National Asset Management Inc. now owns 2,269 shares of the medical instruments supplier's stock valued at $933,000 after buying an additional 241 shares during the last quarter. Kestra Advisory Services LLC raised its position in West Pharmaceutical Services by 7.5% in the 1st quarter. Kestra Advisory Services LLC now owns 3,124 shares of the medical instruments supplier's stock valued at $1,283,000 after buying an additional 219 shares during the last quarter. Finally, Mutual of America Capital Management LLC raised its position in West Pharmaceutical Services by 1.1% in the 1st quarter. Mutual of America Capital Management LLC now owns 9,904 shares of the medical instruments supplier's stock valued at $4,068,000 after buying an additional 104 shares during the last quarter. Institutional investors own 91.98% of the company's stock.
其他幾家機構投資者也調整了對WST的持股。方舟投資管理公司在第一季度收購了西方製藥服務公司的新股份，價值約為179,000美元。未來資產全球投資有限公司在第一季度收購了西方製藥服務公司的新股份，價值約為441.2萬美元。National Asset Management Inc.在第一季度將其在West Pharmtics Services的頭寸提高了11.9%。National Asset Management Inc.現在持有這家醫療器械供應商2,269股股票，價值93.3萬美元，該公司在上個季度又購買了241股。Kestra Consulting Services LLC在第一季度將其在西方製藥服務公司的頭寸提高了7.5%。Kestra Consulting Services LLC現在擁有這家醫療器械供應商3,124股股票，價值1,283,000美元，上個季度又購買了219股。最後，美國互惠資本管理有限責任公司在第一季度將其在西部製藥服務公司的頭寸提高了1.1%。美國互惠資本管理公司現在持有這家醫療器械供應商的9,904股股票，價值4,068,000美元，此前在上個季度又購買了104股。機構投資者持有該公司91.98%的股票。
West Pharmaceutical Services Stock Up 0.7 %
西部醫藥服務公司股票上漲0.7%
Shares of West Pharmaceutical Services stock opened at $269.93 on Tuesday. The business's 50 day simple moving average is $312.53 and its 200 day simple moving average is $330.25. West Pharmaceutical Services, Inc. has a 52-week low of $261.31 and a 52-week high of $475.00. The firm has a market cap of $19.99 billion, a PE ratio of 29.96, a P/E/G ratio of 1.08 and a beta of 1.18. The company has a debt-to-equity ratio of 0.09, a quick ratio of 2.41 and a current ratio of 3.13.
週二，西方製藥服務公司的股票開盤報269.93美元。該業務的50日簡單移動均線切入位在312.53美元，200日簡單移動均線切入位在330.25美元。West Pharmtics Services，Inc.的52周低點為261.31美元，52周高位為475.00美元。該公司的市值為199.9億美元，市盈率為29.96倍，市盈率為1.08倍，貝塔係數為1.18。該公司的負債權益比率為0.09，速動比率為2.41，流動比率為3.13。
Insider Buying and Selling
內幕買賣
In other West Pharmaceutical Services news, insider Silji Abraham sold 5,374 shares of the company's stock in a transaction on Monday, August 1st. The shares were sold at an average price of $343.93, for a total transaction of $1,848,279.82. Following the sale, the insider now directly owns 3,201 shares of the company's stock, valued at $1,100,919.93. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.60% of the stock is owned by corporate insiders.
在其他西方製藥服務公司的消息中，內部人士Silji Abraham在8月1日星期一的一筆交易中出售了5374股該公司股票。這些股票的平均價格為343.93美元，總成交金額為1,848,279.82美元。出售後，這位內部人士現在直接持有該公司3201股股票，價值1100,919.93美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的，可以通過這個超級鏈接訪問。公司內部人士持有該公司0.60%的股份。
About West Pharmaceutical Services
關於西方醫藥服務公司
(Get Rating)
(獲取評級)
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
西方製藥服務公司在美洲、歐洲、中東、非洲和亞太地區設計、製造和銷售可注射藥物和保健產品的容器和輸送系統。它分為兩個部分，專有產品和合同製造產品。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on West Pharmaceutical Services (WST)
- Oracle's Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin' It: Investors Keep Visiting McDonald's
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
- 免費獲取StockNews.com關於West Pharmtics Services(WST)的研究報告
- 甲骨文的短期痛苦可能是你的長期收益
- Lucid看起來像是電動汽車的贏家
- 仍然愛着它：投資者繼續光顧麥當勞
- 聯邦快遞剛剛提供了一個買入機會嗎？
- 自動區重新進入拉力賽模式，新高在望
Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating).
想看看還有哪些對衝基金持有WST嗎？訪問HoldingsChannel.com獲取西方製藥服務公司(紐約證券交易所代碼：WST-GET Rating)的最新13F文件和內幕交易。
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.
接受《西部醫藥服務報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對West Pharmtics Services和相關公司的最新新聞和分析師評級的每日簡要摘要。